The Kratom Council

Latest / Regulation

Regulation

Colorado Did Not Need A New Legal Theory. It Wrote A Number Into Law Last Year, And This Month It Collected On It.

Nine plain unmarked cylindrical steel calibration weights standing in a row graduated from small to large on a pale grey bench, with an empty steel measuring scoop resting on its side beside them.

Every enforcement action this publication has reported in the past two months has had the same thing in common, and it is easy to miss because the actions themselves look so different. In each one, somebody had to build an argument.

Texas sued retailers on a deceptive marketing theory. Missouri brought a merchandising practices action. Florida scheduled by emergency rule. Baltimore used a city consumer protection ordinance to reach out-of-state manufacturers. Bellingham, Starkville, Ephrata and Mount Vernon each wrote a prohibition covering a whole category of product. Different tools, different authorities, and one shared feature: none of those jurisdictions had a number on the books saying how much 7-hydroxymitragynine is too much, so each had to reach for something else.

Colorado had a number. On September 21 the state's Attorney General announced a settlement worth one hundred and fifty-two thousand dollars with the owners of a wholesale distributor and a chain of fifteen smoke shops, resolving allegations that included selling kratom products above the limit the state had already set.

What The State Said It Found

As reported, the settlement resolves allegations against the owners of a wholesale distribution company trading as DNB Distro and fifteen retail premises, most of them operating under the Million Smoke N Vape name. The allegations are that the owners failed to ensure their kratom products met the state's labelling and packaging requirements, and that they sold products in which 7-OH exceeded the permitted level.

The terms reported are as notable as the figure. The businesses are required to test the products they sell in Colorado, to keep documentation of what they purchase, and to comply with the Colorado Consumer Protection Act and with the statute that set the limit.

Testing and purchase records are not a penalty. They are a compliance regime, and they are the thing a threshold makes possible. A jurisdiction that has legislated a number can tell a retailer to prove it is under the number. A jurisdiction that has not can only argue about how the product was described.

The Number, And Where It Came From

The limit sits in Colorado Senate Bill 25-072, passed in 2025 and known as the Daniel Bregger Act. Under it, as reported, the amount of 7-OH in a product may not exceed two per cent of that product's total alkaloid content.

The statute reaches further than that single figure. As reported, it also prohibits products that are adulterated with controlled substances or synthesised alkaloids, products designed to appeal to children, and products intended for vaporisation or combustion. It restricts sales to people twenty-one and over and sets packaging, labelling and storage requirements.

The Act carries the name of Daniel Bregger, who as reported died in Denver in 2021. His father has said publicly that his son had consumed a highly concentrated product sold without serving directions or warnings. This publication records why the statute carries that name and does not characterise what any product did or did not do.

Two Thresholds, Two Different Measurements

This is the part an operator should read twice, because the arithmetic does not carry across.

Colorado's limit is expressed as a share of a product's total alkaloid content. The federal threshold that the trade has been waiting on since July, as this publication has reported it, is expressed differently: a percentage by dry weight, or an absolute quantity of one milligram in an article.

Those are different denominators. One asks what fraction of the alkaloids present are 7-OH. The other asks what fraction of the material's weight is 7-OH, or simply how many milligrams are in the thing. A product's position under one of those tests does not tell you its position under the other, and this publication has not modelled any product against either and is not suggesting how any given item would fall.

What can be said plainly is that a company selling into more than one state is not working against a single line. It is working against several, written by different bodies, measured against different denominators, and arriving on different dates.

The Federal Order Still Has Not Issued

The Drug Enforcement Administration published its notice of intent on 7-hydroxymitragynine above a specified threshold on July 6. The notice itself set August 5 as the earliest date the resulting order could publish. As of this publication's most recent check, it has not.

That is now approaching twelve weeks from the notice and more than seven from the date the notice named. In the same period, a state threshold that has been law since 2025 has produced a settlement, a testing obligation and a documentation obligation against a fifteen-store chain.

This publication has made the observation before about state action generally and it holds here in a sharper form. The federal order is the document everyone is watching. It is not the instrument doing the work.

Allegations, Resolved

The matters described above are allegations made by a state law enforcement office and resolved by agreement. This publication has not read the settlement document, does not know what it says about admission or denial of liability, and reports no finding of wrongdoing by any court.

The individual owners are named in the Attorney General's announcement. Their names are withheld here, because identifying two private individuals is not necessary to report what the instrument is or how it worked. The trading names are given because they are the public-facing businesses the settlement obliges to test and document.

What This Report Does Not Establish

Nothing here was read in the original. The Attorney General's release and every outlet that covered it are unreachable from this publication's working environment, so no document was retrieved and nothing is quoted. The account rests on reporting as it appears in search results, which is consistent across the state's own announcement and two separate outlets on the date, the amount, the businesses, the number of premises, the statutory limit and the terms.

This publication has not read the text of Senate Bill 25-072, has not verified the case or file number, and has not established how the state tested the products or what levels it found. Anyone with exposure in Colorado should obtain the statute and the settlement rather than rely on this summary.

This is also the first time this publication has reported on Colorado at all, which is a gap rather than a scoop. The statute has been law since 2025.

Sources

  1. Reporting on the September 21, 2026 announcement by the Colorado Attorney General, as it appears in search results. The originating release and the outlets covering it were not reachable from this publication's working environment and were not opened directly.
  2. Colorado Attorney General — announcement of the settlement (September 21, 2026)
  3. Colorado Politics — "Kratom sellers, Colorado reach settlement" (September 21, 2026)
  4. BizWest — "Smoke shop owners settle with state for $152K" (September 22, 2026)
  5. CBS News Colorado — on the Daniel Bregger Act and its requirements
  6. Colorado Senate Bill 25-072, the Daniel Bregger Act — bill record
  7. Federal Register — DEA notice of intent, 7-hydroxymitragynine above a specified threshold, Docket No. DEA-1570 (July 6, 2026)
  8. The Kratom Council — "The States Did Not Wait For Washington" (September 1, 2026)
  9. The Kratom Council — "The City Kratom Ordinances Have Turned Criminal" (September 10, 2026)

← Back to all coverage

Get new reporting by email